Latest News
FDA Approves Rasonque, Revolution Medicines Stock Holds Steady
Revolution Medicines (RVMD) received FDA approval for Rasonque in pancreatic cancer, but shares rose only 0.8% as investors awaited launch details.
Target Stock Rebounds After Costume Controversy Erases $2.9B
Target (TGT) shares edged up 0.6% Wednesday, recovering from a $2.9B market value loss triggered by a controversial Halloween costume. Analysts remain cautious.
Qantas Doubles Loyalty Rewards in 8-Day Push Ahead of FY Results
Qantas launches an 8-day double rewards promotion for its 18.3 million loyalty members, with Loyalty EBIT up 12% to A$286 million. Stock slips 0.32% ahead of Thursday's earnings.
SolarEdge Jumps on UBS Upgrade, FCC Rule Seen Boosting Pricing Power
SolarEdge shares climbed 7.7% after UBS upgraded the stock to Buy and raised its price target to $42, citing FCC inverter restrictions that could boost pricing power.
Apple's Mac mini M6 Launch Lifts Shares 1.1% Despite Higher Price
Apple (AAPL) shares gained 1.1% following the Mac mini M6 launch, priced at $899 (up 12.5%). The company's Mac division posted record revenue of $10.4 billion last quarter.
McDonald's McGold Card Campaign Launches in Australia with Daily App Deals
McDonald's launches its Australian McGold Card campaign with 30 daily app deals and nine lifetime prizes worth A$561,600. MCD shares slipped 0.39%.
Kanzhun's $230M Dividend and Strong Q2 Send Shares Up 16%
Kanzhun (BZ) shares surged 16% after declaring a $230M dividend and posting strong Q2 results, with operating margin expanding to 36% and revenue up 14.1%.
Meta Shares Slip as $10B Legal Charge Weighs on Settlement Deal
Meta's shares pared gains after a $10 billion legal charge from a teen-safety settlement hit, raising concerns about costs and platform changes.
CD Projekt Shares Dip as Free Witcher 3 Remaster Aims to Expand Player Base
CD Projekt shares fell 0.8% despite the free Witcher 3 remaster announcement, as analysts weigh its potential to expand the player base ahead of a paid expansion.
Boston Scientific Plunges 4% on Cyberattack Revenue Warning
Boston Scientific shares dropped 4.1% after a cyberattack disrupted order processing and shipments, threatening up to $369 million in Q3 revenue.
Abercrombie Jumps 22% on $100M Tariff Refund, Raised Outlook
Abercrombie & Fitch shares soared 22% after a $100M tariff refund boosted Q2 EPS and raised FY2026 outlook. Underlying performance also beat expectations.
Photronics Stock Jumps 23% on Record High-End Chip Mask Sales
Photronics (PLAB) rallied 23% in premarket trading after reporting record high-end IC mask mix of 44% and quarterly results that beat expectations.